Medtronic (MDT) Soars 3.13% on Digital Orthopedics Push

Generated by AI AgentAinvest Pre-Market Radar
Friday, Jul 11, 2025 7:03 am ET1min read

Medtronic's stock rose 3.13% in pre-market trading on July 11, 2025, reflecting positive market sentiment and strategic initiatives.

Medtronic recently launched the AiLLIANCE China Edition (ACE) clinical research project in Shanghai, focusing on the local application and value of its AiBLETM digital orthopedic ecosystem. This initiative aims to accelerate the digital transformation of orthopedics, enhance diagnostic and treatment capabilities, and improve healthcare accessibility. The project, supported by leading domestic orthopedic research centers, will evaluate the clinical and economic value of digital orthopedics, driving technological advancements and scaling up intelligent applications in the field.

In a significant organizational move,

appointed Chad Spooner as the Chief Financial Officer (CFO) of its diabetes business unit, MiniMed. Spooner, with over 25 years of experience in healthcare, consumer, and industrial sectors, will lead the financial strategy as MiniMed prepares to become an independent publicly traded company. This appointment underscores Medtronic's commitment to the long-term success of MiniMed, which is expected to benefit from Spooner's expertise in strategic transformations and cost optimization.

Comments



Add a public comment...
No comments

No comments yet